MAPK1 and drug-induced dyskinesia: Similarly, García-Montes and colleagues found that downregulating mGluR5 in D1 neurons in a mouse model of Parkinson’s disease attenuated dyskinesia by decreasing ERK and FosB expression in the striatum [70].